Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Syphilis Serology Quality Controls

Products are for professional/laboratory use only.

Accurun®  Serology controls are some of the most respected in the industry and are relied upon by many world-class laboratories to ensure assay performance.

Accurun can help improve confidence in your test results and assist in maintaining regulatory compliance when part of your laboratory’s quality assurance program.

Accurun 155 Syphilis Positive Control

External control for use with in vitro serology assays that detect IgG antibodies to Treponema pallidum (Syphilis).

  • Ready-to-use control
  • Formulated to challenge your assay
  • Made from natural plasma or serum; closely resembles an actual patient sample
  • Non-reactive for HBsAg and antibodies to HIV 1/2, HTLV, and HCV
  • Analytes included: Treponema pallidum IgG
  • Regulatory Status: IVD
  • Multiple users across ANZ

Accurun 156 Reagin (Syphilis) Positive Control

External control for use with in vitro assays that detect Syphilis reagin (Syphilis RPR assays).

  • Ready-to-use control
  • Formulated to challenge your assay
  • Made from natural plasma or serum; closely resembles an actual patient sample
  • Nonreactive for HBsAg and antibodies to HIV 1/2, HTLV, and HCV
  • Analytes included: Syphilis reagin
  • Regulatory Status: IVD
  • Multiple users across ANZ

Would you be interested in evaluating these controls?

Contact Us Here >



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article